IL-21R expression on CDS+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditis

被引:18
|
作者
Liu, Wei [2 ]
Dienz, Oliver [1 ]
Roberts, Brian [1 ]
Moussawi, Mohamad [1 ]
Rincon, Mercedes [1 ]
Huber, Sally A. [1 ]
机构
[1] Univ Vermont, Colchester, VT 05446 USA
[2] Harbin Med Univ, Affiliated Hosp 1, Harbin 150001, Heilongjiang Pr, Peoples R China
基金
美国国家卫生研究院;
关键词
Coxsackievirus B3; Myocarditis; IL-21R; CD8 T cells; Autoimmunity; BALB/C MICE; B-3; MYOCARDITIS; CUTTING EDGE; DIFFERENTIATION; INDUCTION; RESPONSES; AUTOIMMUNITY; PHENOTYPE; VIRUSES; DISEASE;
D O I
10.1016/j.yexmp.2012.03.009
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
IL-21 is a multi-functional cytokine which can promote survival, proliferation and activation of T and B lymphocytes including CD8 T cells. Previous studies have shown that autoimmune CD8+ T cells are the primary pathogenic effector cell in coxsackievirus B3 (CVB3) induced myocarditis in C57BI/6 mice. To evaluate the role of IL-21 in promoting CD8+ T cell mediated cardiac injury in myocarditis, C57BI/6 and IL-21RKO mice were infected with CVB3. IL-21RKO mice developed significantly less myocarditis than C57BI/6 animals although cardiac virus titers were equivalent between the mouse strains. Numbers of CD8+IFN gamma+ cells were decreased in IL-21RKO mice but numbers of either CD4+IFN gamma+ or CD4+IL-4+ cells were not significantly different from C57BI/6 animals indicating a selective effect of IL-21 signaling on the CD8+ T cell response. To confirm that IL-21 signaling exclusively functions at the level of the CD8+ T cell in CVB3 induced myocarditis, purified CD8+ cells were isolated from either C57BI/6 or IL-21RKO donors and adoptively transferred into CD8KO recipients prior to CVB3 infection. CD8KO recipients given either C57BI/6 or IL-21RKO CD8+ cells showed equivalent reconstitution of the CD8+ cells in the spleen but the recipients given C57BI/6 CD8+ cells showed significantly greater myocarditis than recipients of IL-21RKO CD8+ cells. These data demonstrate that IL-21 signaling directly in the CD8+ cell population is required for CVB3-induced myocarditis. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 50 条
  • [31] IL-21R signalling is essential for the maintenance of CD8 T-cell responses in persistent LCMV docile infection
    Froenlich, A.
    Kisielow, J.
    Weber, J.
    Oxenius, A.
    Kopf, M.
    SWISS MEDICAL WEEKLY, 2008, 138 : 7S - 7S
  • [33] Frontline Science: Late CD27 stimulation promotes IL-7Rα transcriptional re-expression and memory T cell qualities in effector CD8+ T cells
    Dong, Han
    Buckner, Andrew
    Prince, Jessica
    Bullock, Timothy
    JOURNAL OF LEUKOCYTE BIOLOGY, 2019, 106 (05) : 1007 - 1019
  • [34] Donor cell persistence and activation-induced unresponsiveness of peripheral CD8+ T cells
    Ehl, S
    Barchet, W
    Oehen, S
    Aichele, P
    Hombach, J
    Hengartner, H
    Zinkernagel, RM
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (03) : 883 - 891
  • [35] Expression and function of NK cell receptors in CD8+ T cells
    McMahon, CW
    Raulet, DH
    CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (04) : 465 - 470
  • [36] B cells help CD8+ T-cell responses
    Peng, Jun
    BLOOD, 2016, 127 (06) : 667 - +
  • [37] Minimal activation of memory CD8+ T cell by tissue-derived dendritic cells favors the stimulation of naive CD8+ T cells
    Gabrielle T Belz
    Sammy Bedoui
    Fiona Kupresanin
    Francis R Carbone
    William R Heath
    Nature Immunology, 2007, 8 : 1060 - 1066
  • [38] Unique Features of Naive CD8+ T Cell Activation by IL-2
    Cho, Jae-Ho
    Kim, Hee-Ok
    Kim, Kyu-Sik
    Yang, Deok-Hwan
    Surh, Charles D.
    Sprent, Jonathan
    JOURNAL OF IMMUNOLOGY, 2013, 191 (11): : 5559 - 5573
  • [39] Delayed IL-21 treatment preferentially expands peptide-specific CD8+ T cells by reducing bystander activation of T cells
    Kim, Seon-Hee
    Park, Sang-Yoon
    Lim, Myong Cheol
    Lee, Eun Sook
    Lee, Eun Gyeong
    Han, Seoung-Eun
    Kim, Young-Ho
    Kwon, Byoung S.
    Choi, Beom K.
    IMMUNOTHERAPY, 2019, 11 (06) : 497 - 513